Interpret each hazard ratio as a measure of how an explanatory variable is associated with the event’s instantaneous risk, relative to the comparison represented in the analysis. This allows investigators to quantify covariate effects rather than relying only on treatment-group or patient-group labels. In medicine, those estimates can support prognosis assessment and identification of factors linked to recurrence or survival.
Leaving the baseline hazard unspecified makes the model semiparametric: it estimates the relationship between covariates and hazard without requiring a fully specified form for the underlying baseline hazard. This focuses interpretation on relative effects expressed as hazard ratios. The approach is useful when the scientific goal is to compare risks associated with explanatory variables rather than impose a particular baseline-risk pattern.
Right-censored participants still contribute information because they are included up to the point when follow-up ends without the event being observed. This allows analyses to use participants who remain event-free at study completion instead of treating them as unusable observations. In medical studies, that feature is important when observation periods end before every participant experiences the outcome.
It requires the relative risks associated with covariates to remain constant over time. If that assumption does not fit the study data, hazard-ratio interpretations may not adequately represent how associations change during follow-up. Analysts should therefore assess the proportional-hazard assumption alongside model fit before using the results for prognosis, treatment comparison, or risk stratification.
It is appropriate when the outcome is measured as time until an event and investigators need to compare treatment groups or evaluate several explanatory variables simultaneously. In medicine, applications include clinical-trial treatment comparisons, prognosis estimation, and identifying factors associated with survival or disease recurrence. The resulting covariate estimates can also contribute to patient risk stratification.
By considering explanatory variables within the same model, Cox regression can quantify their associations with the event while accounting for the other variables included in that analysis. This supports identification of factors with independent associations, rather than limiting interpretation to a single characteristic at a time. Such results can help organize prognostic information and inform medical risk stratification.